Grantham Mayo Van Otterloo & Co. LLC Boosts Holdings in Elevance Health, Inc.

Institutional investor increases stake in healthcare company

Published on Mar. 8, 2026

Grantham Mayo Van Otterloo & Co. LLC, a major investment management firm, has increased its holdings in Elevance Health, Inc. (NYSE: ELV) by 23.7% in the third quarter. The firm now owns approximately 2.5 million shares of the healthcare company, making it one of Elevance Health's largest institutional investors.

Why it matters

This move by Grantham Mayo Van Otterloo & Co. LLC suggests the investment firm sees significant potential in Elevance Health's future performance and growth prospects. As a major shareholder, the firm's increased stake could signal confidence in the company's strategic direction and ability to navigate the evolving healthcare landscape.

The details

According to a recent 13F filing with the SEC, Grantham Mayo Van Otterloo & Co. LLC added 483,340 shares of Elevance Health to its portfolio during the third quarter. This brings the firm's total holdings in the company to 2,523,450 shares, or approximately 1.14% of Elevance Health's outstanding shares. The investment firm cited Elevance Health's strong financial performance and market position as factors behind the increased stake.

  • Grantham Mayo Van Otterloo & Co. LLC increased its holdings in Elevance Health during the 3rd quarter of 2026.

The players

Grantham Mayo Van Otterloo & Co. LLC

A major investment management firm that has increased its stake in Elevance Health, Inc.

Elevance Health, Inc.

A large U.S.-based health benefits company that provides a broad range of health insurance products and related services.

Got photos? Submit your photos here. ›

The takeaway

Grantham Mayo Van Otterloo & Co. LLC's increased investment in Elevance Health signals the firm's confidence in the healthcare company's long-term growth potential. As a major institutional shareholder, the firm's actions could influence market sentiment and investor interest in Elevance Health.